Literature DB >> 102732

The surface properties of Neisseria gonorrhoeae: determinants of susceptibility to antibody complement killing.

M E Ward, P R Lambden, J E Heckels, P J Watt.   

Abstract

Monovalent rabbit antisera were prepared to highly purified gonococcal lipopolysaccharide (LPS), to pili and to two major purified outer envelope proteins. All these antisera were free from significant specific IgM antibody and were standardized to 4 microgram specific IgG antibody per test, permitting accurate comparisons between the different gonococcal surface antigens as triggers of the complement-dependent bactericidal reaction. LPS was the most effective antigen at inducing a bactericidal response to homologous and heterologous gonococci, followed by the two individual outer envelope proteins. Pili were relatively ineffective. Strain P9 gonococci grown in vivo or which possessed a 'capsule' in vitro were more resistant to serum killing than the non-capsulated parent strain. One highly susceptible strain, F62, which was killed by complement in the absence of any LPS antibody, was able to directly activate complement by the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102732     DOI: 10.1099/00221287-108-2-205

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  7 in total

Review 1.  Gonococcal vaccines.

Authors:  E C Tramont
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 2.  Systemic gonococcal infection.

Authors:  J D Ross
Journal:  Genitourin Med       Date:  1996-12

3.  A study of inactivation of Chlamydia trachomatis by normal human serum.

Authors:  A P Johnson; M F Osborn; S Rowntree; B J Thomas; D Taylor-Robinson
Journal:  Br J Vener Dis       Date:  1983-12

4.  Genetics of serum resistance in Neisseria gonorrhoeae: the sac-1 genetic locus.

Authors:  J G Cannon; T J Lee; L F Guymon; P F Sparling
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies.

Authors:  M Virji; J E Heckels
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Use of transformation to construct Neisseria gonorrhoeae strains with altered lipooligosaccharides.

Authors:  D C Stein; E F Petricoin; J M Griffiss; H Schneider
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

Review 7.  Gonorrhea - an evolving disease of the new millennium.

Authors:  Stuart A Hill; Thao L Masters; Jenny Wachter
Journal:  Microb Cell       Date:  2016-09-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.